Abstract 13059: In-vitro Sorbent-Mediated Removal of Edoxaban From Human Plasma and Albumin Solution

Background: Direct oral anticoagulants are currently the drugs of choice for stroke prophylaxis in patients with atrial fibrillation. While an antidote is currently available - andexanet alfa, its ...